Studies investigating CD8-mediated tumor immunity demonstrate that mTOR controls memory CD8+ T cell differentiation by regulating two transcription factors, T-bet and Eomesodermin (Eomes) (74, 75). The gene discussed is EOMES; the disease is neoplasm.